Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone | Patent Publication Number 20230277660
US 20230277660 A1Publication DateSep 7, 2023
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsMing Qi
Zhilong Yuan
Rajesh Bandekar
Pamela Clemens
Christoph Heuck
Zhilong Yuan
Rajesh Bandekar
Pamela Clemens
Christoph Heuck
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.